/Table 11 (AMF nomenclature) Other information concerning the executive corporate officers
| Executive corporate officers | Employment contract | Supplementary pension plan | Indemnities or benefits due or payable on cessation or change in functions | Indemnities under a non-compete clause |
|---|---|---|---|---|
| Management Board | Management BoardEmployment contract
|
Management BoardSupplementary pension plan
|
Management BoardIndemnities or benefits due or payable on cessation or change in functions
|
Management BoardIndemnities under a non-compete clause
|
| Arthur Sadoun, Chairman | Arthur Sadoun, ChairmanEmployment contract No |
Arthur Sadoun, ChairmanSupplementary pension plan No |
Arthur Sadoun, ChairmanIndemnities or benefits due or payable on cessation or change in functionsYes(1) | Arthur Sadoun, ChairmanIndemnities under a non-compete clauseYes(1) |
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2026 | First appointment: June 1, 2017Expiry of term of office: September 14, 2026 Employment contract
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2026 Supplementary pension plan
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2026 Indemnities or benefits due or payable on cessation or change in functions
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2026 Indemnities under a non-compete clause
|
| Anne-Gabrielle Heilbronner | Anne-Gabrielle HeilbronnerEmployment contract Yes |
Anne-Gabrielle HeilbronnerSupplementary pension planNo(2) | Anne-Gabrielle HeilbronnerIndemnities or benefits due or payable on cessation or change in functionsYes(3) | Anne-Gabrielle HeilbronnerIndemnities under a non-compete clauseYes(3) |
| First appointment: September 15, 2014 Expiry of term of office: September 14, 2026 | First appointment: September 15, 2014 Expiry of term of office: September 14, 2026 Employment contract
|
First appointment: September 15, 2014 Expiry of term of office: September 14, 2026 Supplementary pension plan
|
First appointment: September 15, 2014 Expiry of term of office: September 14, 2026 Indemnities or benefits due or payable on cessation or change in functions
|
First appointment: September 15, 2014 Expiry of term of office: September 14, 2026 Indemnities under a non-compete clause
|
| Steve King | Steve KingEmployment contract Yes |
Steve KingSupplementary pension planYes(4) | Steve KingIndemnities or benefits due or payable on cessation or change in functionsYes(4) | Steve KingIndemnities under a non-compete clauseYes(4) |
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 | First appointment: June 1, 2017Expiry of term of office: September 14, 2022Employment contract
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2022Supplementary pension plan
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2022Indemnities or benefits due or payable on cessation or change in functions
|
First appointment: June 1, 2017Expiry of term of office: September 14, 2022Indemnities under a non-compete clause
|
| Michel-Alain Proch | Michel-Alain ProchEmployment contract Yes |
Michel-Alain ProchSupplementary pension planNo(2) | Michel-Alain ProchIndemnities or benefits due or payable on cessation or change in functionsYes(5) | Michel-Alain ProchIndemnities under a non-compete clauseYes(5) |
| First appointment: January 15, 2021 Expiry of term of office: September 14, 2026 | First appointment: January 15, 2021 Expiry of term of office: September 14, 2026 Employment contract
|
First appointment: January 15, 2021 Expiry of term of office: September 14, 2026 Supplementary pension plan
|
First appointment: January 15, 2021 Expiry of term of office: September 14, 2026 Indemnities or benefits due or payable on cessation or change in functions
|
First appointment: January 15, 2021 Expiry of term of office: September 14, 2026 Indemnities under a non-compete clause
|
At December 31, 2022, no members of the Management Board and the Supervisory Board owned more than 1% of the Company’s shares, with the exception of Élisabeth Badinter and her children (6.57%), and Maurice Lévy, who owns directly or indirectly 4,848,159 shares, i.e. 1.91% of the Company’s capital, including 2,509,602 shares owned through a Company belonging to Maurice Lévy and his family.
At December 31, 2022, the members of the Supervisory Board and Management Board (excluding Élisabeth Badinter and her children) directly and indirectly held 6,842,139 shares, i.e. 2.69% of the Company’s share capital, of which 1.91% by Maurice Lévy.
As of December 31, 2022, the members of the Management Board also owned 35,491 stock options, all of which are exercisable. The weighted average exercise price of the options is 52.76 euros per share with these options expiring in 2023 (see Note 32 to the consolidated financial statements in Section 6.6).
The following table shows the interest of each corporate officer in the share capital of the Company at December 31, 2022 by the number of shares and voting rights, as well as the number of shares that each corporate officer has the right to acquire through the exercise of new stock subscription options and existing stock purchase options.
